ArticleJournal of molecular histology2026
Pharmacological inhibition of endoplasmic reticulum stress ameliorates polystyrene nanoplastic-induced renal injury in female Wistar rats.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanoplastics are a relatively new pollutant that has raised growing concern about their deleterious effects on humans. Endoplasmic reticulum (ER) stress is a cellular stress response that helps maintain protein balance in response to internal or external stimuli. The aim of this research was to modulate ER stress in renal tissues by administering 4-PBA to mitigate the nephrotoxicity induced by polystyrene nanoplastics (PSNPs). For this purpose, 24 healthy female Wistar rats were randomly divided into four groups: vehicle control group, PSNPs group, PSNPs + 4-PBA 500 mg/kg group, and PSNPs + 4-PBA 1000 mg/kg group (n = 6). During the experiment, PSNPs (10 mg/kg) were given for 5 weeks, whereas 4-PBA was given for the last two weeks. At the end of the experiment, animals were sacrificed, and tissue samples from the kidney and blood were collected and stored immediately. PSNPs exposure resulted in severe renal dysfunction, including increased serum creatinine, MDA, and nitrite, whereas body weight, kidney weight, and GSH were decreased. Markers related to ER stress, including GRP78, CHOP, and caspase-12, were found to be upregulated, along with distorted renal histopathology in the PSNPs-exposed group. The administration of 4-PBA leads to improvement in histological alterations and biochemical parameters, as well as attenuation of GRP78, CHOP, and caspase-12 expression levels. The results of this study indicate that 4-PBA may serve as a potent intervention to treat PSNP-induced nephrotoxicity. Also, apoptosis through GRP78/CHOP-dependent ER stress signalling plays a significant role in the development of PSNPs-induced nephrotoxicity.
Indexed as
Identifiers
42717112What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.